Raffles Associates LP Has $2.38 Million Stake in Viemed Healthcare, Inc. (NASDAQ:VMD)

Raffles Associates LP grew its holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) by 4.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 362,691 shares of the company’s stock after purchasing an additional 15,000 shares during the quarter. Viemed Healthcare comprises 2.7% of Raffles Associates LP’s portfolio, making the stock its 12th biggest holding. Raffles Associates LP owned approximately 0.93% of Viemed Healthcare worth $2,376,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in VMD. Vanguard Group Inc. raised its stake in Viemed Healthcare by 53.0% during the 1st quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after purchasing an additional 617,009 shares during the last quarter. Kent Lake Capital LLC bought a new stake in shares of Viemed Healthcare in the first quarter valued at about $5,557,000. Bard Associates Inc. grew its position in Viemed Healthcare by 882.0% during the fourth quarter. Bard Associates Inc. now owns 338,335 shares of the company’s stock worth $2,656,000 after buying an additional 303,880 shares in the last quarter. Millrace Asset Group Inc. bought a new position in Viemed Healthcare during the fourth quarter valued at about $1,458,000. Finally, Penbrook Management LLC raised its holdings in Viemed Healthcare by 236.0% in the 2nd quarter. Penbrook Management LLC now owns 231,607 shares of the company’s stock valued at $1,517,000 after acquiring an additional 162,670 shares in the last quarter. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Price Performance

Shares of NASDAQ:VMD opened at $7.31 on Tuesday. The business’s 50 day moving average is $7.27 and its 200-day moving average is $7.56. The company has a current ratio of 1.43, a quick ratio of 1.29 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $283.78 million, a PE ratio of 28.12 and a beta of 1.47. Viemed Healthcare, Inc. has a 1-year low of $5.90 and a 1-year high of $10.44.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.03). The business had revenue of $54.97 million for the quarter. Viemed Healthcare had a return on equity of 8.23% and a net margin of 4.60%.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.